Which immunization apps should you put on your mobile device today? Our app reviewer offers the complete rundown.
Adult Stimulant Use Accounts for Most Recent Growth in ADHD Prescribing in Canada
A population-based study finds stimulant prescribing accelerated after 2020, with the largest increases among adults and women.
Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights
Topics include new findings on oral acromegaly therapy, alcohol and dementia risk, tirzepatide in youth T2D, precision mood care, and LARC outcomes.
Opportunities and Limits of Neuromodulation for Excessive Daytime Sleepiness: Highlights of a Narrative Review
A new review examines whether neuromodulation techniques may help address excessive daytime sleepiness across neurologic and psychiatric conditions.
Weekly Dose Podcast: New Insights on Colonoscopy Adherence, rt-CGM in GDM, Semaglutide Effects, Parent Vaccine Views, and MI Causes
Topics include rideshare support for colonoscopy, rt-CGM benefits in GDM, semaglutide and food noise, vaccine views, and MI etiology.
Fezolinetant Shows Real-World Benefits for Menopausal Symptoms: Daily Dose
Your daily dose of the clinical news you may have missed.
FDA Expands Use of GSK's Gepotidacin as Oral Treatment for Uncomplicated Urogenital Gonorrhea
Gepotidacin becomes the first new oral antibiotic for gonorrhea in over 30 years, offering hope for effective treatment options.